The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
Safety and efficacy of brigatinib (AP26113) in advanced malignancies, including ALK+ non–small cell lung cancer (NSCLC).
 
D. Ross Camidge
Honoraria - ARIAD
Research Funding - ARIAD
 
Lyudmila Bazhenova
Stock and Other Ownership Interests - Epic Sciences
Honoraria - Novartis
Consulting or Advisory Role - Boehringer Ingelheim; Clovis Oncology; Seagen
Speakers' Bureau - Genentech; Pfizer
Research Funding - ARIAD; Astellas Pharma; Astex Pharmaceuticals; AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Eisai; Heat Biologics; Johnson & Johnson; Lilly; MedImmune; Merck; Mirati Therapeutics; NanoCarrier; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Boehringer Ingelheim; Clovis Oncology; Genentech; Pfizer; Seagen
 
Ravi Salgia
No Relationships to Disclose
 
Corey J. Langer
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Abbott Biotherapeutics; Bayer/Onyx; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Lilly/ImClone; Merck; Millennium
Research Funding - Advantagene (Inst); Ariad (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Inovio Pharmaceuticals (Inst); Merck (Inst)
 
Kathryn A. Gold
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Pfizer
Research Funding - ARIAD; AstraZeneca; Bristol-Myers Squibb; Puma Biotechnology; Roche/Genentech
 
Rafael Rosell
No Relationships to Disclose
 
Alice Tsang Shaw
Honoraria - Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Genentech; Ignyta; Novartis; Pfizer; Roche Pharma AG
Research Funding - ARIAD (Inst); Genentech (Inst); Novartis (Inst); Pfizer (Inst)
 
Glen J. Weiss
Employment - Cancer Treament Centers of America
Consulting or Advisory Role - Pharmatech
Speakers' Bureau - Amgen; Celgene; Pfizer; Quintiles
Travel, Accommodations, Expenses - Cambridge Healthtech Institute; Pharmatech
 
Narayana I. Narasimhan
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
David J. Dorer
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
Victor M. Rivera
No Relationships to Disclose
 
Timothy Piers Clackson
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
Maureen G Conlan
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
David Kerstein
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
Frank G. Haluska
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
Scott N. Gettinger
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Janssen
Research Funding - ARIAD (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Pfizer (Inst)